GGrantIndex
Sort

78,016 grants matching breast cancer

Improving Perception in Digital Breast Tomography

$903,831
Jeremy M Wolfe · Brigham And Women'S Hospital · R01 · FY2025 · CA

Clinical Protocol and Data Management (Core 012)

$903,736
Dan Toby Vogl · University Of Pennsylvania · P30 · FY2019 · CA

Measuring cellular senescence to predict and prevent peripheral neuropathy

$903,506
Natalia Mitin · Sapere Bio, Inc. · R44 · FY2022 · AG

Cancer Immunotherapy Clinical Trials

$902,872
Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

TARGETING CRIPTO IN BREAST CANCER PLASTICITY

$902,854
University Of Utah · · FY2021 · Defense Health Agency

Preclinical Alzheimers Disease Drug Development of Novel MAPK Inhibitors

$902,779
D. Martin Watterson · Northwestern University At Chicago · U01 · FY2013 · AG

Fox Chase Clinical Epidemiology and Validation Center

$902,705
Fox Chase Cancer Center · U01 · FY2005 · CA

CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHI

$902,691
State University New York Stony Brook · N01 · FY2000 · WH

Development of Natural Product Leads as Anticancer Therapeutics

$902,657
John Beutler · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

(3 of 3) MMC, VICC & TSU: Partners in Eliminating Cancer Disparities

$902,465
Margaret M Whalen · Tennessee State University · U54 · FY2025 · CA

Integrated high throughput proteogenomic data analysis center for CPTAC

$902,381
Denkanikota R Mani · Broad Institute, Inc. · U24 · FY2019 · CA

SPORE in Pancreatic Cancer

$902,341
University Of Alabama At Birmingham · P20 · FY2004 · CA

Research Infrastructure in Minority Institutions (RIMI) at Tougaloo College

$902,235
Beverly Wade Hogan · Tougaloo College · P20 · FY2007 · MD

Targeting breast cancer stem cells

$902,098
Max S. Wicha · University Of Michigan At Ann Arbor · R35 · FY2019 · CA

GWAS Studies

$901,889
Ethan Dmitrovsky · Leidos Biomedical Research, Inc. · N01 · FY2020 · CA

Studies on gene regulation by chromatin organization

$901,661
Terumi Kohwi-Shigematsu · University Of Calif-Lawrenc Berkeley Lab · R37 · FY2012 · CA

Development of a radiation-activatable nanoparticle for lung cancer therapy

$901,390
Jin Xie · Athna Biotech, Inc. · R42 · FY2025 · CA

NEW METHODS FOR CANCER DETECTION

$901,039
Weill Medical College Of Cornell Univ · P01 · FY2000 · CA

Evaluation of Commercial Mammography-Based Artificial Intelligence Algorithms for Breast Cancer Risk Prediction in U.S. Screening Populations

$901,023
Kathryn Paige Lowry · University Of Washington · R37 · FY2025 · CA

Cellularly resolved molecular pathway assessment in biopsies via spectral imaging

$900,963
Richard M. Levenson · Cambridge Research And Instrumentation · R44 · FY2009 · CA

Preclinical Testing of Drug Combinations (HDAC, mTOR, CDK and MYC Inhibitors)

$900,771
Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Myeloid TGFbeta signaling in breast cancer metastasis

$900,751
Li Yang · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Preventing Anthracycline Cardiovascular Toxicity with Statins

$900,665
William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2016 · HL

Human Variants

$900,503
Joann B Sweasy · University Of Vermont & St Agric College · P01 · FY2012 · CA

NANO2 ENHANCES IMMUNOTHERAPY IN TRIPLE NEGATIVE BREAST CANCERS.

$900,418
Nuvox Pharma, L.L.C. · · FY2022 · Defense Health Agency